Selon les derniers rapports financiers de Rigel Pharmaceuticals, l'entreprise dispose de 66.51 Millions d'euros en trésorerie et équivalents de trésorerie.
La trésorerie d'une entreprise, également appelée équivalents de trésorerie (CCE) et investissements à court terme, est le montant d'argent accessible qu'une entreprise possède.
Année | Trésorerie | Changement |
---|---|---|
2024-12-31 | €74.3 M | 44.27% |
2023-12-31 | €51.5 M | -5.09% |
2022-12-31 | €54.26 M | -50.83% |
2021-12-31 | €0.11 Md | 136.75% |
2020-12-31 | €46.6 M | -46.77% |
2019-12-31 | €87.55 M | -22.08% |
2018-12-31 | €0.11 Md | 16.47% |
2017-12-31 | €96.47 M | 35.72% |
2016-12-31 | €71.08 M | -38.45% |
2015-12-31 | €0.11 Md | -1.89% |
2014-12-31 | €0.11 Md | -23.31% |
2013-12-31 | €0.15 Md | -31.92% |
2012-12-31 | €0.22 Md | 18.24% |
2011-12-31 | €0.19 Md | 43.06% |
2010-12-31 | €0.13 Md | 43.24% |
2009-12-31 | €93.05 M | -3.26% |
2008-12-31 | €96.19 M | 29.69% |
2007-12-31 | €74.16 M | -6.32% |
2006-12-31 | €79.17 M | -32.13% |
2005-12-31 | €0.11 Md | 121.56% |
2004-12-31 | €52.65 M | 42.57% |
2003-12-31 | €36.93 M | 41.47% |
2002-12-31 | €26.1 M | -31% |
2001-12-31 | €37.83 M | -32.74% |
2000-12-31 | €56.25 M | 869.95% |
1999-12-31 | €5.79 M |
Entreprise | Trésorerie | différencediff. | Pays |
---|---|---|---|
![]() ChemoCentryx CCXI | N/A | N/A | 🇺🇸 USA |
![]() Sangamo Therapeutics
SGMO | €21.72 M | -67.34% | 🇺🇸 USA |
![]() AstraZeneca AZN | €4.65 Md | 6,897.50% | 🇬🇧 UK |
![]() Amgen AMGN | €7.60 Md | 11,326.87% | 🇺🇸 USA |